Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2020-11-30 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
VAL201 Clinical Trial Full Data Results
Regulatory Filings Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 8402G) from ValiRx PLC on November 30, 2020. It reports the receipt of the full dataset from a Phase 1/2 clinical trial (VAL201) and details the safety, tolerability, and disease impact findings. It also announces an upcoming investor webcast to discuss these findings. Since this document is a detailed report of clinical trial results and data analysis, it most closely aligns with the content of a comprehensive report, rather than just a brief announcement of a report's publication (RPA). However, none of the specific codes (like 10-K, AR, IR) perfectly capture a detailed clinical trial result announcement. Given the context of providing detailed scientific/clinical updates that are not standard financial reports (10-K, IR, ER), and the fact that it is a formal regulatory news service release (RNS), it fits best under the general 'Regulatory Filings' (RNS) category, as it is a specific regulatory disclosure that doesn't match the other specialized categories like Audit Report (AR) or Interim Report (IR). The document length is substantial (13,347 chars), suggesting it is the content itself, not just a placeholder announcement.
2020-11-30 English
Agreement with Kalos Therapeutics
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 7524E' and contains extensive boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and 'Primary Information Provider in the United Kingdom'. The content itself is an announcement of a new agreement between ValiRx PLC and Kalos Therapeutics regarding drug evaluation (KTH222). This is a typical corporate news release disseminated through an official regulatory news service. Since it is a general corporate announcement that doesn't fit the specific categories like ER (Earnings Release), CAP (Financing Update), or DIRS (Director's Dealing), the most appropriate classification is the general regulatory announcement category, RNS.
2020-11-10 English
Total Voting Rights and Block Listing Update
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the header 'RNS Number : 6619D' and concludes with standard RNS disclaimers, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content specifically discusses an update to the 'Total Voting Rights' and 'Block Listing Update' as per DTR 5.6.1, which relates to the total number of shares in issue. This type of mandatory disclosure regarding share capital structure changes or voting rights updates, when presented as a brief announcement, fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a director's dealing (DIRS). Given the explicit RNS branding and the nature of the disclosure, RNS is the most appropriate code.
2020-11-02 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1895 characters) and contains the header "RNS Number : 3521C". It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement disseminated via the RNS system. Since it is a general regulatory announcement that doesn't fit into the more specific categories like DIV, ER, or DIRS, and it is clearly an announcement distributed through the RNS service, the most appropriate classification is Regulatory Filings (RNS).
2020-10-16 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1878 characters) and contains the header "RNS Number : 3513C". It announces a specific, immediate market event: a "Price Monitoring Extension" for a security, which is a type of routine market operational update. The text explicitly states, "This information is provided by RNS, the news service of the London Stock Exchange." This strongly indicates it is a general regulatory announcement that does not fit into the specific financial report categories (like 10-K, ER, IR). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement category.
2020-10-16 English
Exercise of Warrant
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement (4149 characters) distributed via RNS (Regulatory News Service) and explicitly states it contains 'inside information for the purposes of Article 7 of EU Regulation 596/2014'. The content details a specific corporate action: the exercise of warrants resulting in the issuance of new ordinary shares and a resulting change in total issued share capital, which is a mandatory disclosure requirement. Since it is a brief, specific regulatory update that doesn't fit the definitions for ER, CAP, DIV, or DIRS, and it is not an announcement *about* a major report (like an RPA), the most appropriate general category for mandatory, non-specific regulatory disclosures provided via RNS is 'Regulatory Filings' (RNS).
2020-10-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.